As per the report published by Fior Markets, the global bronchial thermoplasty market is expected to grow from USD 59.11 billion in 2017 to USD 166.82 billion by 2025 at a CAGR of 14.14% during the forecast period from 2018-2025. Increasing asthma attacks among the individuals, increasing number of hospitalizations patients suffering from the risk of asthma in the U.S, presence of major players, and rapid technological advancements are some of the factors that led to the growth of bronchial thermoplasty market in North America region..

Global Bronchial Thermoplasty Market by Age Group (18-30 Years, 30 -50 Years, Greater Than 50 Years), Region and Global Forecast 2018-2025.


Prominent companies in the industry include Boston Scientific Corporation and McLaren Healthcare are offering greater opportunities and major players are continuously focused on new product developments and venture capital investments to obtain market share. For instance, in 2010, Boston Scientific Corporation acquired Asthmatx, Inc. Also the Alair system received the U.S. FDA approval in April 2010 and CE Mark in 2011.

Age group segment includes 18-30 years, 30-50 years, and greater than 50 years. 30-50 years age group segment registered value around USD 22.56 billion in 2017 due to large number of individuals belonging from this age group of 30-50 years suffer from severe asthma disease.


Incidence rate of asthma and rise in pollution and dust allergy issue are the key driving factors for the bronchial thermoplasty market. In addition, costly procedure and need skilled operators and developed infrastructure will lead the growth of bronchial thermoplasty market in couple of years. The xxx may limit the growth of market. However, rising cases of asthma globally is expected to boost the bronchial thermoplasty market over the forecast period.

Customization of the Report:
This report can be customized to meet the client’s requirements. Please connect with our sales team (, who will ensure that you get a report that suits your needs.